WITHDRAWN: Updates in Prognostication and Treatment of Waldenström’s Macroglobulinemia
Open Access
- 29 May 2019
- journal article
- withdrawal
- Published by Elsevier BV in Hematology/Oncology and Stem Cell Therapy
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- New developments in the management of Waldenström macroglobulinemiaCancer Management and Research, 2017
- International prognostic scoring system for Waldenström macroglobulinemiaBlood, 2009
- Novel Aspects Pertaining to the Relationship of Waldenström's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and HypoglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2009
- Waldenström macroglobulinaemiaBritish Journal of Haematology, 2007
- Diagnosis and Management of Waldenstrom's MacroglobulinemiaJournal of Clinical Oncology, 2005
- Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceBlood, 2003
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Waldenström's macroglobulinemia in young African‐American adultsAmerican Journal of Hematology, 1999
- Waldenström's macroglobulinemia*Cancer, 1998
- Incidence of Waldenstrom's macroglobulinemiaBlood, 1993